4:56 PM
 | 
Sep 14, 2017
 |  BC Extra  |  Financial News

Aldeyra stock surge continues

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) jumped $4.45 (70%) to $10.80 on Thursday as momentum continued following a Phase IIa data readout on Tuesday showing that ADX-102 ophthalmic solution significantly improved multiple signs and symptoms of dry eye disease (see BioCentury Extra, Sept. 12).

The...

Read the full 212 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >